Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Multi-center, Randomized, Placebo Controlled, Dose-ranging Study to Determine the Efficacy and Safety of SPL7013 Gel (VivaGel®) Administered Vaginally in the Treatment of Bacterial Vaginosis

NCT01201057 is registered in ClinicalTrials.gov with Starpharma Pty Ltd as lead sponsor.

NCT NCT01201057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01201057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Multi-center, Randomized, Placebo Controlled, Dose-ranging Study to Determine the Efficacy and Safety of SPL7013 Gel (VivaGel®) Administered Vaginally in the Treatment of Bacterial Vaginosis
Lead sponsor
Starpharma Pty Ltd
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2010
Completion date
May 31, 2011
Enrollment
132 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis